The DOI matches its Crossref record; the references it cites are not checked yet.
Telepharmacy for the management of cardiovascular patients in the community
Abstract
Telepharmacy is devised to provide pharmacy operations and patient care at a distance and to expand access to healthcare, enhance patients' safety and improve patient outcomes. A variety of technologies, models of care and interventions are used to develop and provide telepharmacy services, serving diversified populations with different pathological conditions, including cardiovascular diseases. Unfortunately, very few randomized controlled studies have evaluated the clinical efficacy of the implementation of telepharmacy services in the management of various cardiovascular conditions, with the strongest evidence being limited to telemonitoring studies in the areas of hypertension and diabetes. Although the clinical efficacy of telepharmacy, and its cost effectiveness, are far from being fully proved, the inclusion of telepharmacy services in healthcare models may offer the unique opportunity to increase access to screening and improve care of cardiovascular conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
The citation lists haven’t been fetched yet
References 41 · Cited by 51
Research works printed but not linked: 38
- George, 2010, The evolving role of the community pharmacist in chronic disease management - a literature review, Ann Acad Med Singapore, 39, 861, 10.47102/annals-acadmedsg.V39N11p861 · DOI
- Tan, 2014, Pharmacist services provided in general practice clinics: a systematic review and meta-analysis, Res Social Adm Pharm, 10, 608, 10.1016/j.sapharm.2013.08.006 · DOI
- Omboni, 2018, Effectiveness of pharmacist's intervention in the management of cardiovascular diseases, Open Heart, 5, 10.1136/openhrt-2017-000687 · DOI
- Alexander, 2017, ASHP Statement on Telepharmacy, Am J Health Syst Pharm, 74, e236, 10.2146/ajhp170039 · DOI
- Niznik, 2017, Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: a systematic review, Res Social Adm Pharm
- Littauer, 2017, Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review, Pharm Pract (Granada), 15, 1134, 10.18549/PharmPract.2017.04.1134 · DOI
- Traynor, 2013, Telepharmacy services bring new patient care opportunities, Am J Health Syst Pharm, 70, 565, 10.2146/news130025 · DOI
- Omboni, 2015, The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring, Expert Rev Cardiovasc Ther, 13, 209, 10.1586/14779072.2015.1001368 · DOI
- Green, 2008, Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial, JAMA, 299, 2857, 10.1001/jama.299.24.2857 · DOI
- Green, 2013, Blood pressure 1 year after completion of web-based pharmacist care, JAMA Intern Med, 173, 1250, 10.1001/jamainternmed.2013.1037 · DOI
- Fishman, 2013, Improving BP control through electronic communications: an economic evaluation, Am J Manag Care, 19, 709
- Robins, 2013, Barriers and facilitators to evidence-based blood pressure control in community practice, J Am Board Fam Med, 26, 539, 10.3122/jabfm.2013.05.130060 · DOI
- Ralston, 2014, Home blood pressure monitoring, secure electronic messaging and medication intensification for improving hypertension control: a mediation analysis, Appl Clin Inform, 5, 232, 10.4338/ACI-2013-10-RA-0079 · DOI
- Magid, 2011, A multimodal blood pressure control intervention in 3 healthcare systems, Am J Manag Care, 17, e96
- Welch, 2011, Systolic blood pressure control after participation in a hypertension intervention study, Am J Manag Care, 17, 473
- Lambert-Kerzner, 2010, Patients' perspectives of a multifaceted intervention with a focus on technology: a qualitative analysis, Circ Cardiovasc Qual Outcomes, 3, 668, 10.1161/CIRCOUTCOMES.110.949800 · DOI
- Margolis, 2012, Design and rationale for home blood pressure telemonitoring and case management to control hypertension (HyperLink): a cluster randomized trial, Contemp Clin Trials, 33, 794, 10.1016/j.cct.2012.03.014 · DOI
- Margolis, 2015, A successful multifaceted trial to improve hypertension control in primary care: Why did it work?, J Gen Intern Med, 30, 1665, 10.1007/s11606-015-3355-x · DOI
- Pawloski, 2016, A substudy evaluating treatment intensification on medication adherence among hypertensive patients receiving home blood pressure telemonitoring and pharmacist management, J Clin Pharm Ther, 41, 493, 10.1111/jcpt.12414 · DOI
- Asche, 2016, Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management, J Am Soc Hypertens, 10, 873, 10.1016/j.jash.2016.09.004 · DOI
- Kerby, 2012, Adherence to blood pressure telemonitoring in a cluster-randomized clinical trial, J Clin Hypertens (Greenwich), 14, 668, 10.1111/j.1751-7176.2012.00685.x · DOI
- Magid, 2013, A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program, Circ Cardiovasc Qual Outcomes, 6, 157, 10.1161/CIRCOUTCOMES.112.968172 · DOI
- Shane-McWhorter, 2015, Pharmacist-provided diabetes management and education via a telemonitoring program, J Am Pharm Assoc (2003), 55, 516, 10.1331/JAPhA.2015.14285 · DOI
- Klug, 2011, Integrating telehealth technology into a clinical pharmacy telephonic diabetesmanagement program, J Diabetes Sci Technol, 5, 1238, 10.1177/193229681100500533 · DOI
- Maxwell, 2016, Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population, Pharmacotherapy, 36, 348, 10.1002/phar.1719 · DOI
- McFarland, 2012, Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus, Pharmacotherapy, 32, 420, 10.1002/j.1875-9114.2011.01038.x · DOI
- Carter, 2018, Cluster-randomized trial to evaluate a centralized clinical pharmacy service in private family medicine offices, Circ Cardiovasc Qual Outcomes, 11, 10.1161/CIRCOUTCOMES.117.004188 · DOI · Paper page
- Gay, 2006, Reinforced follow-up for children and adolescents with type 1 diabetes and inadequate glycaemic control: a randomized controlled trial intervention via the local pharmacist and telecare, Diabetes Metab, 32, 159, 10.1016/S1262-3636(07)70263-X · DOI
- O'Connor, 2014, Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes, Diabetes Care, 37, 3317, 10.2337/dc14-0596 · DOI
- Salvo, 2012, Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care, Ann Pharmacother, 46, 29, 10.1345/aph.1Q512 · DOI
- Fera, 2014, Role of a care transition pharmacist in a primary care resource center, Am J Health Syst Pharm, 71, 1585, 10.2146/ajhp130684 · DOI
- Alsabbagh, 2012, Pharmacist intervention in cardiac rehabilitation: a randomized controlled trial, J Cardiopulm Rehabil Prev, 32, 394, 10.1097/HCR.0b013e318272bbf2 · DOI
- Ma, 2010, Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease, Cholesterol, 2010, 10.1155/2010/383281 · DOI
- Singh, 2015, Implementation and outcomes of a pharmacist-managed clinical video telehealth anticoagulation clinic, Am J Health Syst Pharm, 72, 70, 10.2146/ajhp130750 · DOI
- Lowres, 2014, Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study, Thromb Haemost, 111, 1167, 10.1160/TH14-03-0231 · DOI · Paper page
- Shinozaki, 2010, [Risk management of QT-prolonging drugs by community pharmacists using a mobile electrocardiograph], Yakugaku Zasshi, 130, 1597, 10.1248/yakushi.130.1597 · DOI
- Nathan, 2018, The CVS effect on American Health Insurance, Manag Care, 27, 39
- Dafny, 2018, Does CVS-Aetna spell the end of business as usual?, N Engl J Med., 378, 593, 10.1056/NEJMp1717137 · DOI
Metadata
- Authors
- Omboni, S., & Tenti, M.
- Affiliations
- Sechenov University (RU)
- Italian Institute of Telemedicine (IT)
- Corresponding author
- Omboni, Stefano
- ORCID
- Omboni, Stefano
- Venue
- Trends in Cardiovascular Medicine
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 29
- Issue
- 2
- Pages
- 109-117
- ISSN
- 1050-1738 (ISSN-L)
- OpenAlex
- W2883761681
- Cited by
- 51
- References
- 41
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 6 · 2023: 10 · 2022: 9 · 2021: 9 · 2020: 3 · 2019: 5
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Cardiovascular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- telepharmacy, cardiovascular care, remote patient monitoring, hypertension, diabetes mellitus, health care access, patient safety, cost-effectiveness, community pharmacy, remote patient care
- MeSH terms
- Cardiovascular Agents, Cardiovascular Diseases, Community Pharmacy Services, Humans, Patient Care Team, Pharmacists, Telemedicine, Delivery of Health Care, Integrated, Professional Role
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review